Global Mesenchymal Stem Cells Market Professional Survey Report 2016
- QYR590928
- 106 Pages
- June 2016
- Pharmaceuticals
Product types including
Bone cells
Cartilage cells
Muscle cells
Fat cells
The segment applications including
Hematopoietic stem cell transplantation
Tissue repair damage
Autoimmune diseases
As gene therapy vectors.
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
FCB-Phamicell
MEDIPOST
Anterogen
Osiris Therapeutics
American Type Culture Collection Inc. (ATCC)
Anterogen Co., Ltd.
Apceth GmbH & Co. KG
BioCardia Inc.
BioRestorative Therapies Inc.
Bone Therapeutics SA
BrainStorm Cell Therapeutics Inc.
CellGenix Technologie Transfer GmbH
Celprogen Inc.
Cesca Therapeutics Inc.
Cyagen Biosciences Inc.
Kite Pharma Inc.
Medipost Co. Ltd.
Mesoblast Ltd.
Orthofix International N.V.
Osiris Therapeutics Inc.
Stemedica Cell Technologies Inc.
With 21 top producers.
Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Mesenchymal Stem Cells
1.1 Definition and Specifications of Mesenchymal Stem Cells
1.1.1 Definition of Mesenchymal Stem Cells
1.1.2 Specifications of Mesenchymal Stem Cells
1.2 Classification of Mesenchymal Stem Cells
1.2.1 Bone cells
1.2.2 Cartilage cells
1.2.3 Muscle cells
1.2.4 Fat cells
1.3 Applications of Mesenchymal Stem Cells
1.3.1 Hematopoietic stem cell transplantation
1.3.2 Tissue repair damage
1.3.3 Autoimmune diseases
1.3.4 As gene therapy vectors.
1.4 Industry Chain Structure of Mesenchymal Stem Cells
1.5 Industry Overview and Major Regions Status of Mesenchymal Stem Cells
1.5.1 Industry Overview of Mesenchymal Stem Cells
1.5.2 Global Major Regions Status of Mesenchymal Stem Cells
1.6 Industry Policy Analysis of Mesenchymal Stem Cells
1.7 Industry News Analysis of Mesenchymal Stem Cells
2 Manufacturing Cost Structure Analysis of Mesenchymal Stem Cells
2.1 Raw Material Suppliers and Price Analysis of Mesenchymal Stem Cells
2.2 Equipment Suppliers and Price Analysis of Mesenchymal Stem Cells
2.3 Labor Cost Analysis of Mesenchymal Stem Cells
2.4 Other Costs Analysis of Mesenchymal Stem Cells
2.5 Manufacturing Cost Structure Analysis of Mesenchymal Stem Cells
2.6 Manufacturing Process Analysis of Mesenchymal Stem Cells
3 Technical Data and Manufacturing Plants Analysis of Mesenchymal Stem Cells
3.1 Capacity and Commercial Production Date of Global Mesenchymal Stem Cells Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Mesenchymal Stem Cells Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Mesenchymal Stem Cells Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Mesenchymal Stem Cells Major Manufacturers in 2015
4 Global Mesenchymal Stem Cells Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Mesenchymal Stem Cells Capacity and Growth Rate Analysis
4.2.2 2015 Mesenchymal Stem Cells Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Mesenchymal Stem Cells Sales and Growth Rate Analysis
4.3.2 2015 Mesenchymal Stem Cells Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Mesenchymal Stem Cells Sales Price
4.4.2 2015 Mesenchymal Stem Cells Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Mesenchymal Stem Cells Gross Margin
4.5.2 2015 Mesenchymal Stem Cells Gross Margin Analysis (Company Segment)
5 Mesenchymal Stem Cells Regional Market Analysis
5.1 North America Mesenchymal Stem Cells Market Analysis
5.1.1 North America Mesenchymal Stem Cells Market Overview
5.1.2 North America 2011-2016E Mesenchymal Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Mesenchymal Stem Cells Sales Price Analysis
5.1.4 North America 2015 Mesenchymal Stem Cells Market Share Analysis
5.2 Europe Mesenchymal Stem Cells Market Analysis
5.2.1 Europe Mesenchymal Stem Cells Market Overview
5.2.2 Europe 2011-2016E Mesenchymal Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Mesenchymal Stem Cells Sales Price Analysis
5.2.4 Europe 2015 Mesenchymal Stem Cells Market Share Analysis
5.3 Japan Mesenchymal Stem Cells Market Analysis
5.3.1 Japan Mesenchymal Stem Cells Market Overview
5.3.2 Japan 2011-2016E Mesenchymal Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Mesenchymal Stem Cells Sales Price Analysis
5.3.4 Japan 2015 Mesenchymal Stem Cells Market Share Analysis
5.4 China Mesenchymal Stem Cells Market Analysis
5.4.1 China Mesenchymal Stem Cells Market Overview
5.4.2 China 2011-2016E Mesenchymal Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Mesenchymal Stem Cells Sales Price Analysis
5.4.4 China 2015 Mesenchymal Stem Cells Market Share Analysis
5.5 Southeast Asia Mesenchymal Stem Cells Market Analysis
5.5.1 Southeast Asia Mesenchymal Stem Cells Market Overview
5.5.2 Southeast Asia 2011-2016E Mesenchymal Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Mesenchymal Stem Cells Sales Price Analysis
5.5.4 Southeast Asia 2015 Mesenchymal Stem Cells Market Share Analysis
5.6 India Mesenchymal Stem Cells Market Analysis
5.6.1 India Mesenchymal Stem Cells Market Overview
5.6.2 India 2011-2016E Mesenchymal Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Mesenchymal Stem Cells Sales Price Analysis
5.6.4 India 2015 Mesenchymal Stem Cells Market Share Analysis
6 Global 2011-2016E Mesenchymal Stem Cells Segment Market Analysis (by Type)
6.1 Global 2011-2016E Mesenchymal Stem Cells Sales by Type
6.2 Different Types Mesenchymal Stem Cells Product Interview Price Analysis
6.3 Different Types Mesenchymal Stem Cells Product Driving Factors Analysis
6.3.1 Bone cells Mesenchymal Stem Cells Growth Driving Factor Analysis
6.3.2 Cartilage cells Mesenchymal Stem Cells Growth Driving Factor Analysis
6.3.3 Muscle cells Mesenchymal Stem Cells Growth Driving Factor Analysis
6.3.4 Fat cells Mesenchymal Stem Cells Growth Driving Factor Analysis
7 Global 2011-2016E Mesenchymal Stem Cells Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hematopoietic stem cell transplantation Mesenchymal Stem Cells Growth Driving Factor Analysis
7.3.2 Tissue repair damage Mesenchymal Stem Cells Growth Driving Factor Analysis
7.3.3 Autoimmune diseases Mesenchymal Stem Cells Growth Driving Factor Analysis
7.3.4 As gene therapy vectors. Mesenchymal Stem Cells Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Mesenchymal Stem Cells
8.1 FCB-Phamicell
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 FCB-Phamicell 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 FCB-Phamicell 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.2 MEDIPOST
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 MEDIPOST 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 MEDIPOST 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.3 Anterogen
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Anterogen 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Anterogen 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.4 Osiris Therapeutics
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Osiris Therapeutics 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Osiris Therapeutics 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.5 American Type Culture Collection Inc. (ATCC)
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 American Type Culture Collection Inc. (ATCC) 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 American Type Culture Collection Inc. (ATCC) 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.6 Anterogen Co., Ltd.
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Anterogen Co., Ltd. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Anterogen Co., Ltd. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.7 Apceth GmbH & Co. KG
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Apceth GmbH & Co. KG 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Apceth GmbH & Co. KG 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.8 BioCardia Inc.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 BioCardia Inc. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 BioCardia Inc. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.9 BioRestorative Therapies Inc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 BioRestorative Therapies Inc. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 BioRestorative Therapies Inc. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.10 Bone Therapeutics SA
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Bone Therapeutics SA 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Bone Therapeutics SA 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.11 BrainStorm Cell Therapeutics Inc.
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 BrainStorm Cell Therapeutics Inc. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 BrainStorm Cell Therapeutics Inc. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.12 CellGenix Technologie Transfer GmbH
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 CellGenix Technologie Transfer GmbH 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 CellGenix Technologie Transfer GmbH 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.13 Celprogen Inc.
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Celprogen Inc. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Celprogen Inc. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.14 Cesca Therapeutics Inc.
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Cesca Therapeutics Inc. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Cesca Therapeutics Inc. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.15 Cyagen Biosciences Inc.
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Cyagen Biosciences Inc. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Cyagen Biosciences Inc. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.16 Kite Pharma Inc.
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Kite Pharma Inc. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Kite Pharma Inc. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.17 Medipost Co. Ltd.
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Medipost Co. Ltd. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Medipost Co. Ltd. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.18 Mesoblast Ltd.
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Mesoblast Ltd. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Mesoblast Ltd. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.19 Orthofix International N.V.
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 Orthofix International N.V. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Orthofix International N.V. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.20 Osiris Therapeutics Inc.
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Osiris Therapeutics Inc. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Osiris Therapeutics Inc. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
8.21 Stemedica Cell Technologies Inc.
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Stemedica Cell Technologies Inc. 2015 Mesenchymal Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Stemedica Cell Technologies Inc. 2015 Mesenchymal Stem Cells Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Mesenchymal Stem Cells Consumption Forecast
9.2.2 Europe 2016-2021 Mesenchymal Stem Cells Consumption Forecast
9.2.3 Japan 2016-2021 Mesenchymal Stem Cells Consumption Forecast
9.2.4 China 2016-2021 Mesenchymal Stem Cells Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Mesenchymal Stem Cells Consumption Forecast
9.2.6 India 2016-2021 Mesenchymal Stem Cells Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Mesenchymal Stem Cells Marketing Model Analysis
10.1 Mesenchymal Stem Cells Regional Marketing Model Analysis
10.2 Mesenchymal Stem Cells International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Mesenchymal Stem Cells by Regions
10.4 Mesenchymal Stem Cells Supply Chain Analysis
11 Consumers Analysis of Mesenchymal Stem Cells
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Mesenchymal Stem Cells
12.1 New Project SWOT Analysis of Mesenchymal Stem Cells
12.2 New Project Investment Feasibility Analysis of Mesenchymal Stem Cells
13 Conclusion of the Global Mesenchymal Stem Cells Market Professional Survey Report 2016
N/A
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
